Elsevier

Biochemical Pharmacology

Volume 39, Issue 5, 1 March 1990, Pages 911-918
Biochemical Pharmacology

Oxidative activation of the thiophene ring by hepatic enzymes: Hydroxylation and formation of electrophilic metabolites during metabolism of tienilic acid and its isomer by rat liver microsomes

https://doi.org/10.1016/0006-2952(90)90207-2Get rights and content

Abstract

Tienilic acid (TA) is metabolized by liver microsomes from phenobarbital-treated rats in the presence of NADPH with the major formation of 5-hydroxytienilic acid (5-OHTA) which is derived from the regioselective hydroxylation of the thiophene ring of TA. During this in vitro metabolism of TA, reactive electrophilic intermediates which bind irreversibly to microsomal proteins are formed. 5-Hydroxylation of TA and activation of TA to reactive metabolites which covalently bind to proteins both required intact microsomes, NADPH and O2 and are inhibited by metyrapone and SKF 525A, indicating that they are dependent on monooxygenases using cytochromes P-450. Microsomal oxidation of an isomer of tienilic acid (TAI) bearing the aroyl substituent on position 3 (instead of 2) of the thiophene ring also leads to reactive intermediates able to bind covalently to microsomal proteins. Covalent binding of TAI, as that of TA, depends on cytochrome P-450-dependent monooxygenases and is almost completely inhibited in the presence of sulfur containing nucleophiles such as glutathione, cysteine or cyteamine. These results show that 5-OHTA, which has been reported as the major metabolite of TA in vivo in humans, is formed by liver microsomes by a cytochrome P-450-dependent reaction. They also show that two thiophene derivatives, TA and TAI, bind to microsomal proteins after in vitro metabolic activation, TAI giving a much higher level of covalent binding than TA (about 5-fold higher) and a much higher covalent binding: stable metabolites ratio (4 instead of 0.5).

References (19)

There are more references available in the full text version of this article.

Cited by (57)

  • Safety evaluation of substituted thiophenes used as flavoring ingredients

    2017, Food and Chemical Toxicology
    Citation Excerpt :

    Ring epoxidation and S-oxidation are the known primary pathways for biotransformation of thiophene derivatives, and the relative contribution of each pathway is a function of the thiophene substructure. GSH conjugation of the reactive intermediate seems to be a key element in inhibiting covalent binding by acting as a sink for the reactive metabolites, as demonstrated by Dansette et al., (1990, 2005) and Valadon et al., (1996). When comparing the metabolic fate of thiophene derivatives, a pattern emerges that involves the type (Mansuy et al., 1991), position (Dansette et al., 1990; Valadon et al., 1996; Rademacher et al., 2012) and number of substitution groups.

  • The crucial protective role of glutathione against tienilic acid hepatotoxicity in rats

    2008, Toxicology and Applied Pharmacology
    Citation Excerpt :

    Consistent with these gene expression changes, fluctuations in the hepatic GSH levels after the dosing of tienilic acid were shown in the present study. Previous studies using liver microsomal fractions have shown that tienilic acid is metabolized to 5-hydroxytienilic acid through hydroxylation of the thiophene ring by the hepatic drug-metabolizing enzyme CYP2C9 in humans, and similarly by CYP2C11 in rats (Mansuy et al., 1984; Dansette et al., 1990; Dansette et al., 1991). During this process, highly reactive electrophilic intermediates are formed, and hepatic glutathione is consumed in conjugation with the tienilic acid metabolites (Lopez-Garcia et al., 1994; Bonierbale et al., 1999).

  • Monitoring drug-protein interaction

    2006, Clinica Chimica Acta
View all citing articles on Scopus
View full text